...
首页> 外文期刊>Journal of Taibah University Medical Sciences >Erectile dysfunction medication induced-changes in plasma levels of homocysteine and antioxidant enzyme activities as risk factors for cardiovascular disease
【24h】

Erectile dysfunction medication induced-changes in plasma levels of homocysteine and antioxidant enzyme activities as risk factors for cardiovascular disease

机译:勃起功能障碍药物引起血浆同型半胱氨酸水平和抗氧化酶活性的变化是心血管疾病的危险因素

获取原文

摘要

ObjectiveDrugs for erectile dysfunction (ED) act by vasodilatation. Hyperhomocysteinaemia is an independent risk factor for premature atherosclerosis, venous thrombosis and other cardiovascular diseases in both men and women. In addition, oxidative stress has long been regarded as a key pathophysiological mediator that eventually leads to cardiovascular disease, whereas oxidative stress is alleviated by antioxidant enzymes such as superoxide dismutase (SOD) and catalase. The aim of the present study was to determine the levels of plasma homocysteine and antioxidant enzymes in male rats given ED drugs.MethodsMale rats were given a daily dose of 1.48mg/kg body weight sildenafil citrate (Viagra?), 0.285mg/kg vardenafil (Levitra?) or 0.285mg/kg tadalafil (Cialis?) for 3weeks, and plasma levels of homocysteine, SOD and catalase were measured; high- and low-density lipoproteins, total cholesterol and triglycerides were also determined.ResultsThe level of homocysteine was increased by 93% and 67% in plasma of sildenafil- and vardenafil-treated rats, respectively, whereas tadalafil did not change the level significantly. Sildenafil and vardenafil also increased SOD activity by 35% and 46%, respectively; and sildenafil, vardenafil and tadalafil increased the activity of catalase by 33%, 50% and 43%, respectively. A nonsignificant increase in the level of total cholesterol was seen after treatment with all the drugs, and sildenafil, vardenafil and tadalafil increased the levels of high-density lipids by 25%, 41%, and 25%, respectively.ConclusionThe ED medications sildenafil and vardenafil increase the levels of homocysteine and antioxidant enzyme activities. Tadalafil appeared to be safer than the other two drugs, as it did not change the level of homocysteine. Patients taking sildenafil or vardenafil should therefore be advised to take vitamin B12and folic acid in order to reduce the level of homocysteine, as these vitamins play an important role in biotransformation of homocysteine into methionine.
机译:目的用于勃起功能障碍(ED)的药物通过血管舒张起作用。高同型半胱氨酸血症是男女过早动脉粥样硬化,静脉血栓形成和其他心血管疾病的独立危险因素。另外,氧化应激长期以来一直被认为是最终导致心血管疾病的关键病理生理介质,而氧化应激可通过抗氧化剂酶如超氧化物歧化酶(SOD)和过氧化氢酶来缓解。本研究的目的是确定服用ED药物的雄性大鼠血浆中同型半胱氨酸和抗氧化酶的水平。 (Levitra?)或0.285mg / kg他达拉非(Cialis?)3周,并测量血浆同型半胱氨酸,SOD和过氧化氢酶水平;结果测定了西地那非和伐地那非治疗组大鼠血浆中高半胱氨酸水平分别升高了93%和67%,而他达拉非的水平没有明显改变。西地那非和伐地那非也分别使SOD活性提高了35%和46%。西地那非,伐地那非和他达拉非的过氧化氢酶活性分别提高了33%,50%和43%。用所有药物治疗后,总胆固醇水平无显着增加,西地那非,伐地那非和他达拉非分别使高密度脂质的水平分别增加了25%,41%和25%。结论ED药物西地那非和西地那非伐地那非可提高同型半胱氨酸和抗氧化酶活性的水平。他达拉非似乎比其他两种药物更安全,因为它不会改变高半胱氨酸的水平。因此,建议服用西地那非或伐地那非的患者服用维生素B12和叶酸,以降低高半胱氨酸的水平,因为这些维生素在高半胱氨酸向蛋氨酸的生物转化中起重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号